Antiplatelet Therapy with Aspirin in Acute Ischaemic Stroke

• References

• 1 Antiplatelet Trialists’ Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I: Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. British Medical Journal 1994; 308: 081-106
• 2 Koudstaal P, Ciabattoni G, Van GijnJ, Niewenhuis HK, de GrottPG, Sixma JJ, Patrono C. Increased thromboxane biosynthesis in patients with acute cerebral ischaemia. Stroke 1993; 24: 219-223
• 3 Van KootenF, Ciabattoni G, Patrono C, Schmitz PI, Van GijnJ, Koudstaal PJ. Evidence for episodic platelet activation in stroke. Stroke 1994; 25: 278-281
• 4 Antiplatelet Trialists’ Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Brit Med J 1994; 308: 235-246
• 5 Counsell C, Sandercock P. The efficacy and safety of antiplatelet therapy in acute presumed ischaemic stroke; a systematic review of the randomised trials comparing immediate antiplatelet therapy with control. In: Warlow C, Van GijnJ, Sandercock P. (eds), Stroke Module of the Cochrane Database of Systematic Reviews. Cochrane Library, the Cochrane Collaboration, issue 3. Oxford: Update software; 1996. Updated quarterly
• 6 The International Stroke Trial(IST). A randomised trials of aspirin, subcutaneous heparin, both or neither among 19,436 patients with acute presumed ischaemic stroke. International Stroke Trial Collaborative Group. Lancet. 1996. (in press)
• 7 Chinese Acute Stroke Trial (CAST): Rationale, design and progress. Chen ZM, Xie JX, Peto R, Collins R, Liu LS. on behalf of CAST Collaborative group. Cerebrovas Dis 1996; 06 (Suppl. 02) 23